NEW YORK – Investigators from the non-profit Friends of Cancer Research (FOCR)'s tumor mutational burden (TMB) harmonization project shared new data this week from their second phase in which they continue to investigate how available assays differ in their results when applied to the same samples and experiment with methods to harmonize tests to a common reference standard.